Contrôle de l’activité de la maladie avec un intervalle de dose étendu de rituximab/ocrelizumab dans les scléroses en plaques pédiatriques hautement actives
Mélany Venet, Adil Maarouf, J.P. Camdessanché, Bertrand Audoin
{"title":"Contrôle de l’activité de la maladie avec un intervalle de dose étendu de rituximab/ocrelizumab dans les scléroses en plaques pédiatriques hautement actives","authors":"Mélany Venet, Adil Maarouf, J.P. Camdessanché, Bertrand Audoin","doi":"10.1016/j.neurol.2024.02.303","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":504188,"journal":{"name":"Revue Neurologique","volume":"10 2","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2024-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Revue Neurologique","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1016/j.neurol.2024.02.303","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
